Home/Pipeline/Pancreatin

Pancreatin

Exocrine Pancreatic Insufficiency

ApprovedActive

Key Facts

Indication

Exocrine Pancreatic Insufficiency

Phase

Approved

Status

Active

Company

Nordmark Biotech

About Nordmark Biotech

Nordmark Biotech is a privately held, revenue-generating German company with a century of expertise in biologics manufacturing. It operates as a full-service CDMO (Contract Development and Manufacturing Organization) with a strong focus on complex biological active ingredients like enzymes, positioning itself as a global leader in pancreatin and collagenase production. The company leverages its integrated 'Made in Germany' platform, FDA-approved cGMP facilities, and deep technical know-how to serve pharmaceutical clients from development through to commercial supply. Its established commercial products and contract services provide a stable revenue base while it invests in next-generation biotechnological capabilities.

View full company profile

Therapeutic Areas

Gastroenterology Metabolic Disorders Urology Connective Tissue Disorders

Other Exocrine Pancreatic Insufficiency Drugs

Drug	Company	Phase	Status
Pancreatic Elastase Chemiluminescence ELISA	ALPCO Diagnostics	Approved/Commercial	Marketed (IVD in U.S.)
Pancreatin/Pancrelipase USP	Scientific Protein Labs	Approved	Active